B of A Securities Reiterates Buy Rating on Vera Therapeutics, Inc. (VERA)

Market Context

Vera Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $42.96 with a market capitalization of $2.9B.

Analyst coverage from B of A Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Vera Therapeutics, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Vera Therapeutics, Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 07, 2026	B of A Securities	Buy	N/A
May 15, 2026	Evercore ISI Group	Outperform	N/A
Mar 11, 2026	Wolfe Research	Outperform	N/A
Mar 02, 2026	HC Wainwright & Co.	Buy	N/A
Dec 19, 2025	Goldman Sachs	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View VERA Stock Page